West Pharmaceutical Services terminates credit agreement without early termination penalties
WST•West Pharmaceutical Services repaid $130 million outstanding under its 2019 credit agreement on Oct. 26, 2026, and terminated it without early termination penalties. The company entered a new financing agreement providing up to $750 million in revolving advances and a $200 million term loan, with amortization starting March 31, 2028.
1. New financing agreement
West Pharmaceutical Services prepaid and terminated its 2019 credit agreement on Oct. 26, 2026, repaying $130 million outstanding with no early termination penalties. Its new credit agreement provides revolving advances of up to $750 million and a $200 million term loan, with amortization beginning March 31, 2028.
